Results 51 to 60 of about 19,741 (164)

1147-A TNRX-257, a multifunctional LAG3 antagonist and conditional IL2Rϒ/ß partial agonist, is a novel immune stimulant with high dose tolerability in non-human primates

open access: yesJournal for ImmunoTherapy of Cancer, 2023
Rajesh Sharma   +9 more
doaj   +1 more source

Zasocitinib (TAK-279), a Highly Selective Oral TYK2 Inhibitor, Demonstrates Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses of a Randomized Phase IIb Trial. [PDF]

open access: yesDermatol Ther (Heidelb)
Elbuluk N   +11 more
europepmc   +1 more source

Retrospective review on oral delivery of proteins and peptide: Barriers, strategies and clinical applications

open access: yesJournal of Contemporary Pharmacy
Proteins and peptides have gained the attention of researcher in recent era for the cure of many disorders. Proteins possess complex architecture as they formed from amino acid subunits.
Nabila Abdus Salaam, Shaheen Kausar
doaj  

BASECAMP-1 screening study: a model for efficient enrolment in precision oncology clinical trials. [PDF]

open access: yesBMJ Oncol
Hecht JR   +23 more
europepmc   +1 more source

115 Engineered T cells directed at tumors with defined allelic loss

open access: yesJournal for ImmunoTherapy of Cancer, 2020
Agi Hamburger   +11 more
doaj   +1 more source

Editorial: Characterization of biotherapeutic products

open access: yesFrontiers in Bioengineering and Biotechnology, 2022
Anurag S. Rathore   +2 more
openaire   +3 more sources

Quantitative Host Cell Protein Analysis of Antibody-Based Protein Therapeutics Using the Orbitrap Astral Mass Spectrometer. [PDF]

open access: yesJ Am Soc Mass Spectrom
Smith J   +9 more
europepmc   +1 more source

133 Development of novel cellular therapeutics for metastatic and primary CNS malignancies

open access: yesJournal for ImmunoTherapy of Cancer, 2020
Paul Rennert   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy